Robert J Soiffer

During the past 25 years, hematopoietic stem cell transplantation (HSCT) has become accepted as routine treatment for many patients with hematologic malignancies. Traditionally, the primary biologic objectives of HSCT for malignant disease and marrow disorders include the following:

• Delivery of chemotherapy/radiotherapy sufficient to destroy tumor cells

• Infusion of a source of hematopoietic stem cells to replace damaged lymphoid or myeloid progenitors

• Establishment of organ graft tolerance to prevent rejection of donor cells

• Induction of graft-versus-tumor (GVT) activity by allo-geneic immune effector cells

Recent laboratory and clinical observations on the biology of transplantation have challenged many of the fundamental beliefs and practices established over the past quarter century. Insights into graft-versus-host disease (GVHD), graft-versus-leukemia (GVL) activity, stem cell engraftment, donor selection, minimal residual disease (MRD), infectious complications, and treatment-related organ dysfunction all have contributed to revisions and refinements in the current approach to potential transplant recipients.

A Disquistion On The Evils Of Using Tobacco

A Disquistion On The Evils Of Using Tobacco

Among the evils which a vitiated appetite has fastened upon mankind, those that arise from the use of Tobacco hold a prominent place, and call loudly for reform. We pity the poor Chinese, who stupifies body and mind with opium, and the wretched Hindoo, who is under a similar slavery to his favorite plant, the Betel but we present the humiliating spectacle of an enlightened and christian nation, wasting annually more than twenty-five millions of dollars, and destroying the health and the lives of thousands, by a practice not at all less degrading than that of the Chinese or Hindoo.

Get My Free Ebook


Post a comment